BioCentury
ARTICLE | Top Story

Teva mum on CEO rumors

January 3, 2014 12:53 AM UTC

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) declined to comment on a media report in an Israeli financial newspaper that the company will name Erez Vigodman, a Teva director, as CEO later this month at the annual JPMorgan Healthcare Conference. Vigodman is president and CEO of agrochemical company Makhteshim Agan Industries Ltd. (Airport City, Israel), which also declined to comment on the rumor. He would succeed Eyal Desheh, who has been serving as Teva's interim president and CEO since October, when former President and CEO Jeremy Levin abruptly departed (see BioCentury, Nov. 4, 2013). ...